Skip to main content
logo
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,030.00
+85.00 (2.15%)
At close: Aug 24, 2026

Jin Yang Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
22,80422,28729,69412,34012,3089,538
Depreciation & Amortization
2,5572,4092,0242,6552,2912,154
Loss (Gain) From Sale of Assets
-29.93-31.3377.14-0.86-24.9-9.53
Asset Writedown & Restructuring Costs
-28,009-29,000-24,919-2,263-3,556-1,451
Loss (Gain) From Sale of Investments
593.51112.38621.539.6597.9613.48
Provision & Write-off of Bad Debts
-111.281,630-1,4491,47050.09-1,383
Other Operating Activities
7,8256,2165,6821,0382,5673,235
Change in Accounts Receivable
1,8951,446-2,755-2,754-918.28132.24
Change in Inventory
-414.07-999.182,457-2,056-6,332-1,180
Change in Accounts Payable
-245.53-1,1781,862-756.942,227-1,827
Change in Unearned Revenue
-96.65-40.5-30.13---
Change in Other Net Operating Assets
3,984-1,385-473.3-1,148-1,263-7,251
Operating Cash Flow
10,7531,46512,7928,5347,4481,971
Operating Cash Flow Growth
11.92%-88.55%49.91%14.58%277.96%-68.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7,914-4,266-90,060-682.28-3,218-2,516
Sale of Property, Plant & Equipment
301.360.910.9125.099.55
Sale (Purchase) of Intangibles
-1,739-1,563-397.44-851.25-1,423-207.08
Investment in Securities
-3,254-246.184,2474,775-7,950-1,528
Other Investing Activities
-230.54-163.96-66.35-7-266.8-36.19
Investing Cash Flow
-13,760-6,385-86,2763,236-12,833-4,278

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-9,462----
Long-Term Debt Issued
-5,58576,500--16,000
Total Debt Issued
100,07815,04776,500--16,000
Short-Term Debt Repaid
--9,462----6,000
Long-Term Debt Repaid
--1,480-4,756-5,678-189.12-129.92
Total Debt Repaid
-97,697-10,942-4,756-5,678-189.12-6,130
Net Debt Issued (Repaid)
2,3814,10571,744-5,678-189.129,870
Issuance of Common Stock
3,1243,124----
Repurchase of Common Stock
-----2,574-
Dividends Paid
-2,120-1,714-1,619-1,616-1,118-1,118
Other Financing Activities
368-17020-110-1,700100
Financing Cash Flow
3,7535,34470,145-7,404-5,5818,852

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.280.03--0.68--
Miscellaneous Cash Flow Adjustments
--0---
Net Cash Flow
747.05423.93-3,3384,365-10,9666,544

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,838-2,801-77,2687,8514,230-545.86
Free Cash Flow Growth
---85.62%--
Free Cash Flow Margin
2.28%-2.32%-68.18%8.38%5.55%-0.87%
Free Cash Flow Per Share
--224.88-6265.96629.22314.65-47.82
Levered Free Cash Flow
-261.4-6,198-85,3707,659-1,894-4,291
Unlevered Free Cash Flow
1,143-4,765-84,2108,518-1,091-4,161

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2,1372,1601,13219.4614.5387.13
Cash Income Tax Paid
365.191,8502,339172.11,130430.46
Change in Working Capital
5,123-2,1571,061-6,715-6,286-10,125